Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)

Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)

<p style="text-align:justify;"> <b>Objectives:</b> This study sought to examine the effect of statin therapy hospitalizations for heart failure (HFH) in patients in the CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) trial.<br/><br/> <...

Podrobná bibliografie
Hlavní autoři:	Rogers, J, Jhund, P, Perez, A, Böhm, M, Cleland, J, Gullestad, L, Kjekshus, J, Van Veldhuisen, D, Wikstrand, J, Wedel, H, McMurray, J, Pocock, S
Médium:	Journal article
Jazyk:	English
Vydáno:	Elsevier 2014

Podobné jednotky

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Autor: Erik Tandberg Askevold, a další
Vydáno: (2015-01-01)

Rosuvastatin in older patients with systolic heart failure.
Autor: Florkowski, C, a další
Vydáno: (2008)

Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis
Autor: Kotecha, D, a další
Vydáno: (2017)

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
Autor: Cleland, J, a další
Vydáno: (2017)

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
Autor: Gounari, P, a další
Vydáno: (2010)

Rosuvastatin safety and efficacy in coronary heart disease patients
Autor: I. V. Sergienko, a další
Vydáno: (2006-10-01)

Eplerenone in patients with systolic heart failure and mild symptoms
Autor: Rogers, J, a další
Vydáno: (2012)

Acute renal failure due to rhabdomyolysis in relation to abiraterone and rosuvastatin
Autor: Melissa Cintra, a další
Vydáno: (2023-05-01)

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
Autor: Tousoulis, D, a další
Vydáno: (2010)

Perioperative rosuvastatin in cardiac surgery
Autor: Zheng, Z, a další
Vydáno: (2016)

Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products
Autor: Jure Zakrajšek, a další
Vydáno: (2017-12-01)

The Antimycotic Activity of Rosuvastatin
Autor: Zahraa Qasim
Vydáno: (2022-12-01)

Current perspectives on rosuvastatin
Autor: Hu M, a další
Vydáno: (2013-04-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
Autor: S. R. Gilyarevsky
Vydáno: (2015-12-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
Autor: S. R. Gilyarevsky
Vydáno: (2015-12-01)

Rosuvastatin-Induced reversible rhabdomyolysis
Autor: Sangeeta Pradhan, a další
Vydáno: (2023-01-01)

Rosuvastatin induced photolocalized purpura
Autor: Marwa Thabouti, a další
Vydáno: (2022-09-01)

Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial
Autor: Sang-Hyeon Ju, a další
Vydáno: (2024-03-01)

The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Autor: Venkata Narla, a další
Vydáno: (2009-11-01)

The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.
Autor: Kaspar Broch, a další
Vydáno: (2014-01-01)

The year in cardiology: heart failure. The year in cardiology 2019
Autor: J.G.F. Cleland, a další
Vydáno: (2020-04-01)

THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
Autor: V. V. Kukharchuk, a další
Vydáno: (2013-06-01)

The influence of the intestinal microflora to the efficacy of Rosuvastatin
Autor: Lijun Wang, a další
Vydáno: (2018-06-01)

Reducing cardiovascular risk: an emphasis on rosuvastatin
Autor: Anikin G.S., a další
Vydáno: (2017-11-01)

Analysis of genetic aspects of therapy with Rosuvastatin
Autor: Samat Kozhakhmetov, a další
Vydáno: (2016-06-01)

Preparation and optimization of microemulsion of rosuvastatin calcium
Autor: B Zalak Patel, a další
Vydáno: (2012-01-01)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
Autor: Paolo Rubba, a další
Vydáno: (2009-04-01)

Debate: Statins should be used in patients with heart failure
Autor: Kjekshus John
Vydáno: (2001-11-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
Autor: Sandeep Joshi, a další
Vydáno: (2017-12-01)

Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales
Autor: Emdin, C, a další
Vydáno: (2016)

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve)
Autor: Kristensen, S, a další
Vydáno: (2017)

Rethinking heart failure clinical trials: the heart failure collaboratory
Autor: Mutaz Alkalbani, a další
Vydáno: (2024-01-01)

P5.04 EFFECT OF ROSUVASTATIN ON THE ECHOLUCENCY OF THE COMMON CAROTID INTIMA–MEDIA THICKNESS: THE METEOR TRIAL
Autor: L. Lind, a další
Vydáno: (2011-11-01)

Characteristics of heart failure managed in primary care in Europe: the IMPROVEMENT of heart failure survey
Autor: Cleland, J, a další
Vydáno: (2001)

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
Autor: Dickstein, K, a další
Vydáno: (2010)

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
Autor: Dickstein, K, a další
Vydáno: (2010)

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
Autor: Kotecha, D, a další
Vydáno: (2016)

Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS
Autor: Shi Zhang, a další
Vydáno: (2020-11-01)

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM‐Preserved
Autor: Rogers, J, a další
Vydáno: (2013)

Perioperative rosuvastatin in cardiac surgery - Author's reply
Autor: Casadei, B, a další
Vydáno: (2016)